Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,063 | 270 | 99.2% |
| Education | $50.00 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,928 | 87 | $0 (2024) |
| GlaxoSmithKline, LLC. | $860.29 | 22 | $0 (2024) |
| ABBVIE INC. | $746.30 | 37 | $0 (2024) |
| Amgen Inc. | $501.11 | 23 | $0 (2024) |
| PFIZER INC. | $198.12 | 12 | $0 (2024) |
| GENZYME CORPORATION | $157.40 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $149.44 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $147.37 | 3 | $0 (2022) |
| Shire North American Group Inc | $135.20 | 2 | $0 (2019) |
| Lilly USA, LLC | $107.69 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $954.17 | 39 | Novo Nordisk Inc ($406.47) |
| 2023 | $1,285 | 60 | GlaxoSmithKline, LLC. ($426.13) |
| 2022 | $1,142 | 70 | Novo Nordisk Inc ($525.37) |
| 2021 | $1,690 | 75 | Novo Nordisk Inc ($529.76) |
| 2020 | $460.17 | 12 | Novo Nordisk Inc ($162.19) |
| 2019 | $272.04 | 10 | AstraZeneca Pharmaceuticals LP ($119.70) |
| 2018 | $257.63 | 5 | Shire North American Group Inc ($123.55) |
| 2017 | $51.87 | 1 | GENZYME CORPORATION ($51.87) |
All Payment Transactions
272 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: VACCINE | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: RESPIRATORY | ||||||
| 10/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: PAIN | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.63 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Bone Health | ||||||
| 09/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: PAIN | ||||||
| 09/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.63 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: RESPIRATORY | ||||||
| 09/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardio-renal | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Bone Health | ||||||
| 06/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Gastroenterology | ||||||
| 06/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Obesity | ||||||
| 06/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: RESPIRATORY | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Bone Health | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 473 | 623 | $85,178 | $44,717 |
| 2022 | 10 | 369 | 515 | $68,342 | $39,754 |
| 2021 | 10 | 259 | 314 | $38,768 | $24,936 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 230 | $43,160 | $20,016 | 46.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $12,000 | $6,486 | 54.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 64 | 64 | $7,360 | $5,302 | 72.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,900 | $3,946 | 80.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 17 | $3,965 | $2,232 | 56.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $3,420 | $1,998 | 58.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $4,570 | $1,310 | 28.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 63 | 63 | $2,205 | $1,159 | 52.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 49 | 49 | $1,225 | $901.11 | 73.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 46 | 57 | $513.00 | $478.80 | 93.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $560.00 | $437.50 | 78.1% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2023 | 11 | 16 | $400.00 | $240.16 | 60.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 18 | 20 | $900.00 | $211.14 | 23.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 106 | 235 | $39,205 | $21,905 | 55.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 50 | 50 | $5,420 | $4,209 | 77.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 29 | 29 | $6,440 | $3,849 | 59.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 20 | $4,340 | $2,963 | 68.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,430 | $2,721 | 61.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,675 | $2,279 | 48.7% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 48 | 48 | $1,570 | $908.40 | 57.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 31 | 31 | $775.00 | $576.80 | 74.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 19 | $1,055 | $200.63 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 38 | 48 | $432.00 | $141.87 | 32.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 90 | 144 | $23,040 | $14,989 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 23 | 23 | $4,050 | $2,998 | 74.0% |
About Dr. Grant Below, DO
Dr. Grant Below, DO is a Family Medicine healthcare provider based in Clarkston, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2017. The National Provider Identifier (NPI) number assigned to this provider is 1457888588.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Grant Below, DO has received a total of $6,113 in payments from pharmaceutical and medical device companies, with $954.17 received in 2024. These payments were reported across 272 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($6,063).
As a Medicare-enrolled provider, Below has provided services to 1,101 Medicare beneficiaries, totaling 1,452 services with total Medicare billing of $109,408. Data is available for 3 years (2021–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clarkston, MI
- Active Since 05/19/2017
- Last Updated 10/26/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1457888588
Products in Payments
- Ozempic (Drug) $764.23
- UBRELVY (Drug) $572.83
- Rybelsus (Drug) $422.87
- NURTEC ODT (Drug) $323.46
- EVENITY (Biological) $273.78
- RYBELSUS (Drug) $251.44
- AREXVY (Drug) $250.24
- SHINGRIX (Biological) $229.74
- DUPIXENT (Biological) $209.88
- Wegovy (Drug) $198.98
- TRELEGY ELLIPTA (Drug) $137.81
- NUCALA (Biological) $124.94
- CINRYZE (Drug) $123.55
- FASENRA (Drug) $119.70
- Prolia (Biological) $114.14
- TRULICITY (Drug) $94.74
- Vascepa (Drug) $91.33
- MYRBETRIQ (Drug) $90.77
- NEXLETOL (Drug) $85.20
- VRAYLAR (Drug) $77.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarkston
Dr. Larry Baylis, D.o, D.O
Family Medicine — Payments: $13,475
Dorothy White-Williams, M.d, M.D
Family Medicine — Payments: $7,926
Dr. Joyce Lewis, M.d, M.D
Family Medicine — Payments: $7,511
Dr. Katherine French, Do, DO
Family Medicine — Payments: $7,438
Dr. Timothy Oneill, Do, DO
Family Medicine — Payments: $6,524
Dr. Salomi Rami, Do, DO
Family Medicine — Payments: $6,150